The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Polypharmacy and Medication Management in Older Adults
Abstract
Polypharmacy in older adults is a global problem that has recently worsened. Approximately 30% of adults aged 65 years and older in developed countries take 5 or more medications. Although prescribed and over-the-counter medications may improve a wide range of health problems, they also may cause or contribute to harm, especially in older adults. Polypharmacy in older adults is associated with worsening of geriatric syndromes and adverse drug events. Given the risks and burdens of polypharmacy and potentially inappropriate medications, nurses must use patient-centered approaches and nonpharmacologic strategies to treat common symptoms and to optimize patient function and quality of life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Strategies to manage polypharmacy and potentially inappropriate medications (PIMs) in older adults often overlook the role of exercise prescription [538,539].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [538]
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
STOPP/START criteria for potentially inappropriate prescribing in older people: version 2
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M., Ryan, C. A., & Gallagher, P. (2014) · Age and Ageing · doi:10.1093/ageing/afu145 · Cited by 2,412
Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting
Gurwitz, J. H., Field, T. S., Harrold, L. R., Rothschild, J. M., DeBellis, K. R., Seger, A. C., Cadoret, C. A., Fish, L. S., Garber, L., Kelleher, M., et al. (2003) · JAMA · doi:10.1001/jama.289.9.1107 · Cited by 1,666
Reducing Inappropriate Polypharmacy
Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Couteur, D. G. L., Rigby, D., Gnjidic, D., Mar, C. D., Roughead, E. E., Page, A. T., et al. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.0324 · Cited by 1,594
US Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014
Shehab, N., Lovegrove, M. C., Geller, A. I., Rose, K. O., Weidle, N. J., & Budnitz, D. S. (2016) · JAMA · doi:10.1001/jama.2016.16201 · Cited by 664
Optimising drug treatment for elderly people: the prescribing cascade
Rochon, P. A., & Gurwitz, J. H. (1997) · BMJ · doi:10.1136/bmj.315.7115.1096 · Cited by 639
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477
Risk Factors for Adverse Drug Events Among Nursing Home Residents
Field, T. S., Gurwitz, J. H., Avorn, J., McCormick, D., Jain, S., Eckler, M., Benser, M. E., & Bates, D. W. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1629 · Cited by 418
Cooper, J. A., Cadogan, C. A., Patterson, S. M., Kerse, N. M., Bradley, M. C., Ryan, C. A., & Hughes, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-009235 · Cited by 347
Adverse drug events in the outpatient setting: an 11‐year national analysis
Bourgeois, F. T., Shannon, M. W., Valim, C., & Mandl, K. D. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1984 · Cited by 333
Flagged first, then by citations
Research works printed but not linked: 1
- Kapadia, 2010, Potential adverse effects of proton pump inhibitors in the elderly, Clin Geriatr, 18, 24
Cited by
Sorted by citations
Items 101–200 of 245
Impactos da polifarmácia na saúde e na qualidade de vida da população idosa
Bichara, K. D. S., Rezende, J. C., Agostini, L. P., Pereira, M. L. V. B. A., Corrêa, P. R. C., Lisboa, R. P. C., Teodoro, S. P., & Miranda, T. S. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-026 · Cited by 4
Salis, F., Zanda, F., Cherchi, F., Puxeddu, B., Sanna, L., Scudu, C., Serreli, S., Stanisci, L., Cossu, E., & Mandas, A. (2023) · Journal of Medicine and Life · doi:10.25122/jml-2023-0173 · Cited by 4
“A multidimensional evaluation [15, 16] is an essential tool to assess this particular population, which is dealing with various multisystemic comorbidities [17-20] and the potential risks associated with polypharmacy [21, 22].”
MethodTurcotte, V., Kröger, E., Rouleau, R., Durand, É., Poirier, K., & Guénette, L. (2022) · Canadian Journal on Aging / La Revue canadienne du vieillissement · doi:10.1017/s0714980821000672 · Cited by 4
“…in older adults are associated with increasedmorbidity, notably because of the increased risk of adverse events andmedication interactions (Kim & Parish, 2017), leading to a higher risk of falls (Bor et al., 2017; Zia, Kamaruzzaman, & Tan, 2015), emergency department visits (Jeon, Park,…”
BackgroundGomis-Jimeno, F. J., & Lillo‐Crespo, M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20064681 · Cited by 4
Sgnaolin, V., & Engroff, P. (2019) · PAJAR - Pan-American Journal of Aging Research · doi:10.15448/2357-9641.2019.2.34609 · Cited by 4
Kara, H., & Çeçen, D. (2025) · BMC Nursing · doi:10.1186/s12912-025-04107-4 · Cited by 3
Småland-Reksten, A., Agger, A. E., Lian, A., Reseland, J. E., & Krüger, T. B. (2026) · Acta Odontologica Scandinavica · doi:10.2340/aos.v85.45585 · Cited by 3
“Around 30% of the population aged ≥ 65 years in developing countries take five or more medications on a regular basis [2].”
Molina-Mendoza, M. D., de Arellano, M. V. M. R., Delgado‐Silveira, E., & Cruz-Jentoft, A. J. (2022) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2022.08.012 · Cited by 3
A Case study of polypharmacy-induced serotonin syndrome in a cancer patient
Zhu, A. X., Kuhnly, N., Chen, L. L., & Dulu, A. O. (2024) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001048 · Cited by 3
“One third of patients aged 65 years and older are prescribed or taking fi ve or more medications daily, elevating their risk of drug interaction and adverse events (Kim & Parish, 2017; Dean et al., 2024).”
Coates, M., McClure, L. A., Vader, D. T., Finley, M. A., Sefcik, J. S., Gitlin, L. N., & DiMaria-Ghalili, R. A. (2024) · Biological Research For Nursing · doi:10.1177/10998004241289942 · Cited by 5
“The commonly accepted numerical de fi nition of polypharmacy is 5 or more medications daily and due to the categorization of the medication data the polypharmacy group was smaller than if we could have included all participants taking 5 or more medications (Kim & Parish, 2017).”
InfluentialSimakoloyi, N., Erasmus, E., & van Hoving, D. J. (2022) · African Journal of Emergency Medicine · doi:10.1016/j.afjem.2021.11.005 · Cited by 3
“40 transitioning back into the community post discharge [9,10].”
BackgroundGuttier, M. C., Silveira, M. P. T., Tavares, N. U. L., Krause, M. C., Bielemann, R. M., González, M. C., Tomasi, E., Demarco, F. F., & Bertoldi, A. D. (2023) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720230020 · Cited by 3
Lee, J. W., Jeong, S., Han, H., Boyd, C. M., Perrin, N., Simmons, S. F., Green, A. R., Taylor, J. L. W., Boucher, H. R., & Szanton, S. L. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.07.018 · Cited by 3
Assessing Cardiovascular Risk in Geriatric Patients Without Atherosclerotic Cardiovascular Disease
Żurański, W., Nowak, J., Danikiewicz, A., Zubelewicz‐Szkodzińska, B., & Hudzik, B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237133 · Cited by 3
“In turn, polypharmacy was defined as using five or more medications [14].”
Möllmann, H. L., Alhammadi, E., Boulghoudan, S., Kuhlmann, J. M., Mevissen, A., Olbrich, P., Rahm, L. K., & Frohnhofen, H. (2025) · JMIR Research Protocols · doi:10.2196/59203 · Cited by 3
“Comorbid geriatric problems leading to functional limitations are therefore often overlooked, although they represent a major social and economic problem [33,34].”
Valladales‐Restrepo, L. F., Lengua, M. D., Castro-Osorio, E. E., Correa-Sánchez, Y., & Machado‐Alba, J. E. (2020) · CES Medicina · doi:10.21615/cesmedicina.34.1.2 · Cited by 3
Zhang, H., Wong, E. L., Wong, S. Y. S., Chau, P. Y. K., Yip, B. H. K., Chung, R. Y., Lee, E. K. P., Lai, F. T. T., & Yeoh, E. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02324-5 · Cited by 3
Use of medication regimen complexity to target services in the community
McDonough, R. P., McDonough, A., & Doucette, W. R. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.12.011 · Cited by 3
Guidelines for Medication Education for Occupational Therapists
Schwartz, J. K. (2022) · The Open Journal of Occupational Therapy · doi:10.15453/2168-6408.1851 · Cited by 3
“An estimated 61% of adults and 89% of seniors take one or more prescription medications every day (Allin et al., 2017; Kim & Parish, 2017; Kirzinger et al., 2019).”
Kwon, C., Lee, B., & Lee, J. A. (2018) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2018.09.011 · Cited by 3
Bongiovani, L. F. L. D. A., Miotto, N., Restelatto, M. T. D. R., Cetolin, S. F., & Beltrame, V. (2021) · Revista de Pesquisa Cuidado é Fundamental Online · doi:10.9789/2175-5361.rpcfo.v13.8644 · Cited by 3
Röhrig, G., Spiritus, A., Hagemeier, A., Derman, S. H. M., Noack, M. J., & Barbe, A. G. (2020) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-020-01827-x · Cited by 3
Devices for Active Targeted Delivery: A Way to Control the Rate and Extent of Drug Administration
Barros, J. F., Sahraoui, P. F., Kalia, Y. N., & Lapteva, M. (2022) · Methods and principles in medicinal chemistry · doi:10.1002/9783527827855.ch14 · Cited by 3
Polypharmacy as a reason for misinterpreting laboratory results in the elderly
İncir, S., & Bolayirli, M. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.05.001 · Cited by 2
Prins, S. R., Damoiseaux‐Volman, B. A., Vermeer, S. E., Bossuyt, P. M., van EEKELEN, R., Bosmans, J. E., van Poelgeest, E. P., Martens, F. M. A. C., Emmelot‐Vonk, M. H., Verstraete, E., et al. (2025) · BMJ Neurology Open · doi:10.1136/bmjno-2025-001297 · Cited by 2
Implementation of medication review type 2a in community pharmacies: a longitudinal survey study
Tobback, E., Wulf, I. D., Wauters, E., Santos, D. M., Patris, S., Dalleur, O., Tommelein, E., Foulon, V., Philippe, G., Vriese, C. D., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1685922 · Cited by 2
The Source of Purchased Medications and Its Impact on Medication Mistakes and Hospitalizations
Coates, M., Granche, J., Sefcik, J. S., & DiMaria-Ghalili, R. A. (2022) · Research in Gerontological Nursing · doi:10.3928/19404921-20220131-02 · Cited by 2
TIME kriterleri ile belirlenen uygunsuz ilaç kullanımı ve kırılganlık arasındaki ilişki
Çavuşoğlu, Ç. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1136024 · Cited by 2
Sukhachev, V. S., Ivanov, S. M., & Dmitriev, A. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923050061 · Cited by 2
Liu, L., Almodóvar, A. S., & Nahata, M. C. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223231205796 · Cited by 2
“27,28 In this study, we did not observe a significant association between the number of medications and high adherence, in part because all patients were receiving eight or more medications concurrently.”
BackgroundKefale, B., Engidaw, M. T., Tesfa, D., Molla, M., Kefale, Y., & Tafere, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1253845 · Cited by 2
“Several studies have found that DRPs cause signi fi cant hospitalizations, with 50% of them being avoidable, and have a signi fi cant negative impact on the health of cancer patients (17 – 19).”
BackgroundEvaluation of an initiative to address polypharmacy in hospitalized older adults
Meaney, C. J., Tjota, N., Pham, K., Prescott, G. M., Doloresco, F., Ott, M., Wahler, R., & Wikerd, Z. (2024) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1978 · Cited by 2
Borazan, N. G., Sürer, H. K., & Ulusal, F. (2024) · Journal of Dependence · doi:10.51982/bagimli.1471584 · Cited by 2
Svensson, M., Ekström, H., Elmståhl, S., & Rosso, A. (2024) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2024.100089 · Cited by 2
Exploring geriatric syndromes among physically disabled older adults: A network analysis
Hu, Q., Zeng, Y., Cai, L. L., Hong, L., Luo, J., Luo, J., & Liang, Y. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.01.013 · Cited by 2
Wang, D., Wang, A., Meng, X., & Liu, L. (2025) · BMC Geriatrics · doi:10.1186/s12877-025-05732-z · Cited by 2
Nadeau, M.-E., Henry, J. L., Lee, T. C., Bortolussi‐Courval, É., Goodine, C., & McDonald, E. G. (2021) · Trials · doi:10.1186/s13063-021-05729-0 · Cited by 2
“With each added drug, the risk of an adverse drug event (ADE) increases [3], as well as the worsening of geriatric syndromes [4].”
BackgroundSiqueira, A. C. G., da Cunha, J. B., Fernandes, J. D. P., Fernandes, A. G. R., Borges, A. O., Lima, P. F. F., Costa, D. R., Pereira, G. S., & Moura, T. T. T. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n1-273 · Cited by 2
Drug storage, polypharmacy and frailty syndrome in older people: an observational study
Tabué-Teguo, M., Villeneuve, R., Hélène-Pelage, J., Cesari, M., Chovino, J., Boire, A., Dramé, M., Simo, N., & Boucaud‐Maitre, D. (2023) · Pan African Medical Journal · doi:10.11604/pamj.2023.45.29.32636 · Cited by 2
“Polypharmacy is defined by the World Health Organization (WHO) as "the administration of many drugs at the same time or the administration of an excessive number of drugs" [5-7].”
BackgroundAn alternative treatment option in older adults with knee osteoarthritis
Güner, D., & Koçyiğit, S. E. (2023) · Wiener klinische Wochenschrift · doi:10.1007/s00508-023-02287-0 · Cited by 2
Tanaka, S., MIYATA, S., YAMATO, J., KUMAGAI, S., KOGAWA, M., Yamori, T., Irie, M., NAKATANI, E., & Okura, T. (2024) · Translational and Regulatory Sciences · doi:10.33611/trs.2024-001 · Cited by 2
Exercise for geriatric psychiatry outpatients: Results from a clinic intervention
Klil‐Drori, S., Klil-Drori Adi, J., Lesage, M., Goodman, A., Diana, E. S., Segal, M., Looper, K. J., Rej, S., & Sekhon, H. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114811 · Cited by 1
Hirai, T., Hanaoka, S., Terakado, Y., Seki, T., & Watanabe, F. (2024) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.3389/jpps.2024.12886 · Cited by 1
Hanaoka, S., Iwabuchi, K., Hirai, T., Seki, T., & Hayashi, H. (2024) · Stroke Research and Treatment · doi:10.1155/srat/2381790 · Cited by 2
Pan, Z., Nie, J., Zhou, X., Wang, S., Chen, H., Zhang, M., & Liu, H. (2025) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaf045 · Cited by 1
Illness Burden and Unmet Patient Needs in Giant Cell Arteritis: Current State and Future Prospects
Sattui, S. E., Corral, M., & O'Donnell, D. C. (2025) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s517664 · Cited by 1
Systematic data analysis of inpatient acute geriatric wards in Austria in 2024
Feichtner, F., Gutheil, J., Mrak, P., Dovjak, P., Goebel, B., Boulgaropoulos, B., Fasching, P., & Iglseder, B. (2026) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-026-01134-x · Cited by 1
“It is estimated that around 30% of people aged 65 and older take five or more pharmacological agents [18].”
Giollo, A., Cioffi, G., Orsolini, G., Idolazzi, L., Carletto, A., Dalbeni, A., Ognibeni, F., Fracassi, E., Gatti, D., Rossini, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-eular.3459 · Cited by 1
Martín-Baeza, L. F. S., & Leiva-Caro, J. A. (2020) · Gerokomos · doi:10.4321/s1134-928x2020000100004 · Cited by 1
Choi, N. G., DiNitto, D. M., Marti, C. N., & Baker, D. (2021) · Drug and Chemical Toxicology · doi:10.1080/01480545.2020.1868494 · Cited by 1
“Harmful effects from cannabis products are likely higher among older adults because they tend to have more chronic health conditions than younger age groups and take multiple medications, which may increase the risk of drug interactions (Adams 2017, Kim and Parish 2017).”
BackgroundFurtado, N. L., Zottich, A. P. B., Bernardina, B. A. D., Perusse, C. B., Anjos, J. P. T., Bachetti, L. G., Ceolin, S., & Corrêa, M. I. (2021) · Brazilian Journal of Health Review · doi:10.34119/bjhrv4n5-396 · Cited by 1
Ciccone, C. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-60912-8.00006-3 · Cited by 1
Microbiome Association of Polypharmacy in Geriatric Population
Pazhani, G. P., Veerapandian, M., Malayandi, R., & Ramamurthy, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_9 · Cited by 1
Home Medication Regimens Increase in Complexity After Admission for Fall in the Older Trauma Patient
Stanley, S. P., DeMario, B. S., Beel, K. T., Lee, M. S., Petitt, J. C., Brown, L. R., Tseng, E. S., & Ho, V. P. (2022) · The American Surgeon · doi:10.1177/00031348221083958 · Cited by 1
“Similarly, the increase in RxCS was signi fi cantly greater for patients 65 years of age relative to patients ≥ 65 years of age (2 [1-4], vs 1 [0-3], P .05) (Table 2).”
BackgroundBłeszyńska-Marunowska, E., Wierucki, Ł., Jagiełło, K., Rewiuk, K., Mitręga, K. A., & Kalarus, Z. F. (2022) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/154624 · Cited by 1
McLarney, M. D., Johnson, T., Bajaj, G., Lee, D. M., & Zheng, J. Y. (2023) · Rehabilitation Oncology · doi:10.1097/01.reo.0000000000000338 · Cited by 1
Umar, T. P., Tanasov, A., Stevanny, B., Agustini, D., Dave, T., Nabhan, A. I., Madany, M., Ibrahim, M., Nguyen, D. H., Jain, S., et al. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-0260-6.ch001 · Cited by 1
Efficient Prediction Adverse Drug-Drug Interactions with Deep Neural Networks
Ahmed, R., Darwish, A. A., & Hassanien, A. E. (2024) · Studies in systems, decision and control · doi:10.1007/978-3-031-63451-2_11 · Cited by 1
Promoting appropriate medication use by leveraging medical big data
Hong, L., Huang, S., Cai, X., Lin, Z., Shao, Y., Chen, L., Zhao, M., & Yang, C. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1198904 · Cited by 2
Intervención educativa sobre polifarmacia y deprescripción en población adulta mayor de Colombia
Sánchez‐Duque, J. A., Molano-Dorado, H., Martínez-Cerón, D. M., Giraldo‐Giraldo, C., Gaviria‐Mendoza, A., Machado‐Duque, M. E., Valladales‐Restrepo, L. F., & Machado‐Alba, J. E. (2025) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2025.101681 · Cited by 1
Understanding the Medication List and Addressing Polypharmacy in Older Adults
Mansour, D. Z., Sharma, K., & Brandt, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-19625-7_16 · Cited by 1
Plácido, A. I., Marante, N., Morgado, M., Herdeiro, M. T., & Roque, F. (2020) · Egitania Sciencia · doi:10.46691/es.v2i25.269 · Cited by 1
Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study
Willink, R. P., Vos, R. C., den Akker, I. L., & Hart, H. E. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01424-w · Cited by 1
Tangianu, G. E. F., & Nardi, R. (2019) · Italian Journal of Medicine · doi:10.4081/itjm.q.2019.8
The Potential Drug-Drug Interactions in Alzheimer Patients’ Treatment
Savran, M., Aşçı, H., Şengeze, N., Önal, Ö., & Demirci, S. (2019) · DergiPark (Istanbul University) · doi:10.22312/sdusbed.599102
Concurrent Use of Prescription Drugs and Herbal Medicinal Products Among Older Adults
Agbabiaka, T. B. (2020) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.22120
Medication Management Education in Primary Care
Marks, C. (2020) · UA Campus Repository (The University of Arizona)
Hayes, C. (2021) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-4411-2.ch001
Life expectancy’s relationship with behavioral factors and polypharmacy in Western Balkan countries
Boshnjaku, A., & Krasniqi, E. (2020) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2020.66.01.009
PREVALÊNCIA E FATORES DE RISCO ASSOCIADOS A POLIFARMÁCIA EM IDOSOS
Lopera, M. C. F., Vargas, A. C. D. F., Gomes, A. L. L. S., Simão, A. A. L., Monteiro, B. I. A. S., PÓVOA, E., Silva, M. S. F., Corrêa, M. E. D. A. P., Franchi, M. G., Nascimento, M. A., et al. (2021) · doi:10.22533/at.ed.0892130098
Khalil, S. D. S., Rodrigues, M. C. S., & Khalil, O. A. K. (2021) · Revista Contexto & Saúde · doi:10.21527/2176-7114.2021.43.11806
Wagner, H.-O. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-15280-1.00103-x
Hayes, C. (2022) · IGI Global eBooks · doi:10.4018/978-1-6684-5295-0.ch066
Cui, Y., Zhu, C., Lian, Z., Han, X., Xiang, Q., Liu, Z., & Zhou, Y. F. (2021) · Research Square · doi:10.21203/rs.3.rs-237825/v1
Catrini, E., Ferrario, L. B., Mazzone, A., Varalli, L., Gatti, F., Cannavacciuolo, L., Ferruzzi, G., & Foglia, E. (2020) · Research Square · doi:10.21203/rs.3.rs-51758/v1
“This topic acquires relevance, since literature evidence declared that polypharmacy in the elderly is estimated to be around 40% of outpatient population, and even higher in selected groups, for example hospitalized patients [13-18].”
BackgroundYe, L., Yang‐Huang, J., Franse, C. B., Rukavina, T., Vasiljev, V., Mattace-Raso, F. U. S., Verma, A., Borrás, T. A., Rentoumis, A., & Raat, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1616586/v1
Hayes, C., Yemm, H., & Graham, Y. (2022) · Journal of Paramedic Practice · doi:10.12968/jpar.2022.14.5.cpd1
Non-psychotropic Drug Interactions among Psychiatric Patients in Bahrain
Tayem, Y. I., Al-Ghadani, M. H., Jahrami, H., & Ali, M. K. (2019) · Arab Gulf Journal of Scientific Research · doi:10.51758/agjsr-03-2019-0012
Danzako, M., Esumi, S., & Zamami, Y. (2022) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.134.102
MANEJO DE DOENÇAS CRÔNICAS DEGENERATIVAS E DEPRESSÃO: DESAFIOS DA POLIFARMÁCIA
Bachur, T. P. R., Rabelo, F. C. S., & Aragão, G. F. (2022) · Revista Intertox de Toxicologia Risco Ambiental e Sociedade · doi:10.22280/revintervol15ed2.520
Asanov, E. O., Dyba, І. А., Holubova, Y. I., & Asanova, S. O. (2022) · Asthma and allergy · doi:10.31655/2307-3373-2022-3-22-26
Predicting Drug Treatment for Hospitalized Patients with Heart Failure
Zhou, L., & Miliou, I. (2023) · Communications in computer and information science · doi:10.1007/978-3-031-23633-4_19
Investigation of Information Printed on The Blister Pack of Loxoprofen Sodium Tablets
Houchi, H., Houchi, Y., Tanaka, H., Yamaguchi, K., Koshino, Y., Miyake, M., & Kosaka, S. (2023) · Journal of Medicine and HealthCare · doi:10.47363/jmhc/2023(5)223
Calidad de vida asociada con polifarmacia en personas con lesiones cutáneas crónicas
de Almeida, E. F., Goulart, J. C. M. R., Moraes, J. T., Lanza, F. M., & Cortez, D. N. (2022) · Journal of Wound Care · doi:10.12968/jowc.2022.31.latam_sup_6.34
Multimorbidity, Ageing, and Frailty
Hayes, C. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-2354-7.ch001
Hayes, C. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-7630-7.ch008
Efficacy of a Flavored Lubricating Oral Spray on Medication Swallowing in Older Individuals
Kavalam, P., Benkart, C., Kim, C., Kalinousky, D., Parbuoni, K. A., Cooke, C. E., & Morgan, J. A. (2023) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2023.252
GÜRCÜ, S., & Kalkan, A. T. (2023) · Kastamonu Medical Journal · doi:10.51271/kmj-0104
Plácido, A. I., Marante, N., Morgado, M., Herdeiro, M. T., & Roque, F. (2019) · Egitania Sciencia · doi:10.46691/es.v2i25.170
Anticoagulation for Nonvalvular Diseases in Patients with a Limited Prognosis #461
Hilton, R., Hayes, M., Somers, E., Brooten, J. K., & Gabbard, J. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2023.0083
Cuidado farmacêutico na alta hospitalar de pacientes submetidos à angioplastia coronariana
Machado, L. P., Costa, G. S., Andrade, Í. R., Aires, R., Martins, M. L. L., Vasquez, E. C., Pereira, T. D. M. C., Amorim, F. G., & Campagnaro, B. P. (2023) · Saúde e Desenvolvimento Humano · doi:10.18316/sdh.v11i2.9578
Development of Appropriate Medicines for Older Patients: An Industrial Perspective
Hughes, K., & Miller, C. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-35811-1_5
Polypharmacy in the elderly: A bibliometric and visualization analysis
Al‐Taani, G. M., Al-Azzam, S. I., Alzoubi, K. H., Sweileh, W. M., & Muflih, S. (2023) · Electronic Journal of General Medicine · doi:10.29333/ejgm/13901
“Also, medical teams are suggested to use nonpharmacological measures with established efficacy instead of medications to address common symptoms in elderly patients [12].”
BackgroundAproximación diagnóstica a las Cefaleas después de los 65 años
Alemán, L. M. C. (2023) · Revista médica de Panamá · doi:10.37980/im.journal.rmdp.20232286
Satisfaction of people at post-working age with pharmacists’ health promotion in Poland
Raczkiewicz, D., Owoc, J., Bojar, I., & Sarecka‐Hujar, B. (2024) · BMC Public Health · doi:10.1186/s12889-024-17751-3
“The vast majority of elderly people take 3 or more medications (polypharmacy) which is associated with the intensification of possible side effects or a decrease in the quality of life [17, 18].”
Backgroundİç Hastalıklarında Temel Semiyoloji
İnan, B. O., Kızmaz, M., Avcı, G. U., Gamsız, T. S., İpek, Y., Gürsoy, V., Heybeli, H., Aykaş, F., Güven, A. T., Kara, S. P., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.683
Park, J., Engström, G., & Ouslander, J. G. (2024) · Journal of Gerontological Nursing · doi:10.3928/00989134-20240312-02
Metadata
- Authors
- Kim, J., & Parish, A. L.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Kim, Jennifer
- ORCID
- Parish, Abby Luck
- Venue
- Nursing Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 52
- Issue
- 3
- Pages
- 457-468
- ISSN
- 0029-6465 (ISSN-L)
- OpenAlex
- W2739733993
- Cited by
- 245
- References
- 45
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 47 · 2023: 44 · 2022: 34 · 2021: 38 · 2020: 15 · 2019: 18 · 2018: 6
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nursing Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Keywords
- polypharmacy, older adults, medication management, potentially inappropriate medications, adverse drug reactions, geriatric syndromes, patient-centered care, non-pharmacological treatment, quality of life, nursing care
- MeSH terms
- Aged, Humans, Polypharmacy, Nurse's Role, Medication Therapy Management, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review